SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-080304
Filing Date
2022-12-16
Accepted
2022-12-16 09:00:29
Documents
16
Period of Report
2022-12-15
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170293-8k_180lifesci.htm   iXBRL 8-K 72084
2 CERTIFICATE OF AMENDMENT OF SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORA ea170293ex3-1_180lifesci.htm EX-3.1 10039
3 PRESS RELEASE DATED DECEMBER 16, 2022 ea170293ex99-1_180lifesci.htm EX-99.1 15724
4 GRAPHIC ex3-1_001.jpg GRAPHIC 16744
  Complete submission text file 0001213900-22-080304.txt   359925

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20221215.xsd EX-101.SCH 3992
6 XBRL DEFINITION FILE atnf-20221215_def.xml EX-101.DEF 26629
7 XBRL LABEL FILE atnf-20221215_lab.xml EX-101.LAB 36680
8 XBRL PRESENTATION FILE atnf-20221215_pre.xml EX-101.PRE 25253
10 EXTRACTED XBRL INSTANCE DOCUMENT ea170293-8k_180lifesci_htm.xml XML 5802
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 221466609
SIC: 2834 Pharmaceutical Preparations